MENU
+Compare
ALKS
Stock ticker: NASDAQ
AS OF
Jul 18, 04:59 PM (EDT)
Price
$29.21
Change
-$0.15 (-0.51%)
Capitalization
4.55B

ALKS Alkermes plc Forecast, Technical & Fundamental Analysis

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas... Show more

Industry: #Biotechnology
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ALKS with price predictions
Jul 17, 2025

Momentum Indicator for ALKS turns positive, indicating new upward trend

ALKS saw its Momentum Indicator move above the 0 level on July 17, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 95 similar instances where the indicator turned positive. In of the 95 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for ALKS just turned positive on July 08, 2025. Looking at past instances where ALKS's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALKS advanced for three days, in of 289 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

ALKS moved below its 50-day moving average on July 14, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ALKS crossed bearishly below the 50-day moving average on June 25, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The 50-day moving average for ALKS moved below the 200-day moving average on July 15, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALKS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ALKS broke above its upper Bollinger Band on July 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ALKS entered a downward trend on July 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALKS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.784) is normal, around the industry mean (62.813). P/E Ratio (8.902) is within average values for comparable stocks, (89.433). ALKS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.124) among similar stocks. P/S Ratio (2.779) is also within normal values, averaging (19.385).

View a ticker or compare two or three
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ALKS is expected to report earnings to rise 178.08% to 36 cents per share on July 29

Alkermes plc ALKS Stock Earnings Reports
Q2'25
Est.
$0.36
Q1'25
Missed
by $0.18
Q4'24
Beat
by $0.30
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.04
The last earnings report on May 01 showed earnings per share of 12 cents, missing the estimate of 31 cents. With 435.41K shares outstanding, the current market capitalization sits at 4.55B.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1 Burlington Road
Phone
+353 17728000
Employees
2100
Web
https://www.alkermes.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TPLGX78.76N/A
N/A
T. Rowe Price Instl Large Cap Core Gr
PEMGX44.99N/A
N/A
Principal MidCap A
RSSYX25.04N/A
N/A
Victory RS Select Growth Y
HNCUX21.18N/A
N/A
Hartford International Growth R6
COSOX12.30N/A
N/A
Columbia Overseas Core Institutional 3

ALKS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALKS has been loosely correlated with ESPR. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ALKS jumps, then ESPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALKS
1D Price
Change %
ALKS100%
+1.77%
ESPR - ALKS
37%
Loosely correlated
+10.71%
COLL - ALKS
35%
Loosely correlated
+1.54%
VTRS - ALKS
35%
Loosely correlated
+2.09%
PRGO - ALKS
35%
Loosely correlated
+0.22%
AMPH - ALKS
34%
Loosely correlated
+2.02%
More